… relationship between immune and clinical responses to establish whether immune monitoring
could be a reliable surrogate marker for evaluating the clinical efficacy of cancer vaccines. …

… cancer immunotherapy. Herein, we critically examine important issues for improving cancer
vaccination … We highlight the importance of proper clinical design in terms of selected groups …

… vaccine platforms should be a concern of cancer vaccine clinical trials, along with clinical …
employed by recent clinical trials of therapeutic cancer vaccines and analyzes them both …

… tumors and metastases after vaccination or reflect a stronger clinical impact of vaccine in a
… which vaccine-induced tumor immunity correlates with the clinical impact of cancer vaccines …

… cancer; however, in this report, we focus on the development of subunit vaccines for the
treatment of HPV-associated cancer. … a cancer vaccine adjuvant was evaluated in clinical trials of …

… antigens as novel targets for vaccine foster new clinical development of cancer vaccines [3]. …
cancer vaccine has been shown to induce specific CD8 + T cells but with no clinical impact […

… Therapeutic cancer vaccines (TCVs) are attractive systemic … Our review highlights key
issues impacting TCVs in clinical … , obstacles, and regulation of cancer vaccines. Most trials of …

… provides an overview of latest advancements in adjuvant and cancer vaccine technologies,
the current clinical status of various adjuvants and their application to cancer vaccines. …

… This Review provides an overview of new results from clinical studies of therapeutic cancer
vaccines directed against tumour-associated antigens and discusses their implications for …

… Most of our learning about vaccines and … cancer vaccines. This review will focus on
FDA-approved and experimental adjuvants being evaluated for therapeutic cancer vaccines and …